Dr Anissa Boumlic-Courtade | Vaccine Market Lead, EMEA
MERCK

Dr Anissa Boumlic-Courtade, Vaccine Market Lead, EMEA, MERCK

Anissa Boumlic-Courtade, PhD is Associate Director for the vaccine initiative in EMEA with Merck. Dr. Boumlic-Courtade joined Merck- in 2009. She has held various positions focused on downstream processing, virus safety, and monoclonal antibody and vaccine manufacturing.  Dr. Anissa Boumlic-Courtade holds a M. Sc. in Biotechnology Engineering from the Ecole Supérieure de Biotechnologie (ESBS) de Strasbourg (France) and a PhD in Molecular Biology & Biochemistry from the University of Strasbourg co-directed with the University of Thessaly (Greece).

Appearances:



Day Two 11th October, Human @ 17:00

Interactive panel: accelerated development of vaccine products to human clinical trials – successes and challenges


More panellists to be announced shortly

Day Three 12th October, Human @ 09:40

Virus safety for viral vaccines and viral vectors

back to speakers